(Q35768769)

English

Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection

scientific article published on February 2007

In more languages
default for all languages
No label defined

No description defined

Statements

Safety of anti-immunoglobulin E therapy with omalizumab in allergic patients at risk of geohelminth infection (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit